v3.26.1
Document and Entity Information
Apr. 20, 2026
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001869105
Document Type 8-K
Document Period End Date Apr. 20, 2026
Entity Registrant Name BridgeBio Oncology Therapeutics, Inc.
Entity Incorporation State Country Code DE
Entity File Number 001-41955
Entity Tax Identification Number 39-3690783
Entity Address, Address Line One 256 E. Grand Avenue
Entity Address, Address Line Two Suite 104
Entity Address, City or Town South San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94080
City Area Code (650)
Local Phone Number 405-4770
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, par value $0.0001 per share
Trading Symbol BBOT
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false